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Abstract: The aim of present work was to develop a new Fadrozole (FDZ)-loaded Poly(D,L-lactide-co– glycolide) 
lactide:glycolide (50:50)(PLGA) nanoparticles for effective delivery of the masculinization drug, Fadrozole, as an 
alternative to commercially available masculinization agents like testosterone (dietary supplementation of 17α-
methyltestosterone) which are steroids and banned in most EU countries. The FDZ-loaded PLGA NPs were pre-
pared by solvent displacement technique. The particle size of FDZ-loaded PLGA NPs was analyzed using LICOMP 
particle size analyser. It was found to be in the range of 60±66.7 nm to 560±66.7 nm with average size of 
201.4±66.7 nm, where the Zeta potential was estimated to be about -20.82 mV, a series of experiments were carried 
out to induce masculinization using FDZ-loaded PLGA nanoparticles during the sex differentiation period. Tilapia, 
Oreochromis  niloticus fry were treated with FTZ-loaded PLGA nanoparticles at dosages 5, 25, 50 and 100ppm/kg 
diet for 10, 15 and 30 days. The results indicated an increase in the proportion of males with dosage and duration of 
treatment. The male percentage was 92.35±0.86 for T7(50 ppm)  at 10 days, 97.76±1.12 for T7 (100 ppm)  at 15 
days and 100 % for both T6 (50ppm) and T7 (100 ppm) at 30 days. This is first time done by using nanotechnology 
efficiently in Tilapia species which is very important Fresh water aquaculture species in present era. Which showed 
increase the male population with lesser dose of nano-encapsulated Fadrozole (FDZ)-loaded PLGA nanoparticles 
drug as compared with naked control Fadrozole (FDZ) drug delivery. 
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INTRODUCTION 
Tilapia  has  been  exacting  as  the  Food  Fish  of  the  
21st century  and  is  widely  known  as  “Aquatic  
chicken” (Khawa et al., 2003). The culture of only 
male tilapia or hybrid is only allowed in India so as to 
evade / detention productive breeding during culture 
period (NABARD, 2016). 
Nanoparticles (NPs) are believed to be the best drug 
delivery system, have substantial potential for drug 
directing means target drug delivery and show numer-
ous benefits over conformist delivery systems like low 
drug requirement, specificity, target drug delivery etc. 
(Otilia et al., 2005, Hughes, G.A., 2005). Drugs conju-
gated with nanoparticles can be targeted to a specific 
site of action with accompaniment decrease in the ex-
tent of drug necessary and amount venomousness 
means toxicity, permitting safe delivery of deadly ther-
apeutic drugs as well as defence of non-goal matters 
and cells from unadorned side effects and indemnities 
(Brannon-Peppas, L., 1995). Since the application of 
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nanoparticle is always associated with the concern of 
its ill effect, recyclable polymeric nanoparticles obli-
gate anew been the choice of the researchers. These 
polymers have already been used as carriers for anti-
cancer agents (Brigger et. al., 2002), (Vauthier et. al., 
2003) With this background, the present research work 
has been designed to develop PLGA loaded fadrozole 
nanoparticles for producing all male population of ti-
lapia Oreochromis  niloticus.  
Only in the later half of the 20th century, use of gonad-
al hormones in the manipulation of sex was initiated 
and the initial studies were mainly carried out on fishes 
having little or no commercial significance. In fish, 
two aromatase iso-forms have been designated, one 
specially articulated in the ovary (implicit by the 
CYP19a gene) and one specially expressed in the brain 
(coded by the CYP19b gene) (Chiang et. al., 2001). 
Tchoudakova et. al., (2011) stated that the gonads, 
aromatase takes revealed to be a key enzyme adaptable 
sexual diversity in fish. During early progress, obstruc-
tive aromatase will distinguish the gonads into testis 
 (Komatsu et. al., 2006), while estrogen administration 
will cause the development of ovaries (Piferrer, F., 
2001). In the recent past decade the Fadrozole a non-
steroidal aromatase inhibitor has been broadly used to 
operate the sex ratio and its effects on gonadal devel-
opment in Nile tilapia (Kwon et. al.,2000 ) (Kwon et. 
al.,2001 ) (Kwon et. al.,2002), common carp(Pandian, 
T. J. and Varadaraj, K., 1987), etc. Fadrozole inhibit-
ing the aromatase enzyme by quickly joining to the 
heme of the cytochrome P450 subunit of the enzyme, 
resulting in a reducing of estrogen biosynthesis in all 
tissues that can result in an elevated level of androgen 
(by preventing the conversion of androgens to estro-
gens), thus leading sex reversal from genetic female to 
phenotypic male. In India,  Das et. al., 2007 did series 
of experiment and he got 100% male population in O. 
mossambicus by administering17α MT through rearing 
medium for 7 to 10 days old fry for a period of 11 to 
19 days at dosage of 5 and 10 µg/ l water. It is possible 
to manipulate the sex ratio by letrozole (a non-steroidal 
aromatase inhibitor) in the O. mossambicus by oral 
administration. This is first time done by using nano-
technology efficiently in the Nile Tilapia. Which 
showed increase the male population with lesser dose 
of nano-encapsulated  Fadrozole (FDZ)-loaded PLGA 
nanoparticles drug as compared with naked control 
Fadrozole (FDZ) drug delivery. 
MATERIALS AND METHODS 
Chemicals used  
Preparation of FDZ-loaded PLGA NPs: The nano-
particles loaded with Fadrozole were prepared by sol-
vent displacement technique as per the reported meth-
od (Mondal et al., 2008) with some alteration. Briefly, 
a solution of 150mg of PLGA (50:50) in 10ml of ace-
tone taken into a Trsonssterile centrifuge tube conical 
bottom of 50ml capacity and did vortexing using vor-
tex mixture. After that another Tarsons sterile Centri-
fuge Tube Conical Bottom of 50ml capacity containing 
50mg of Fadrozole (drug polymer ratio 1:3) taken into 
the 20ml of acetone with vortexing using vortex mix-
ture. This prepared vortex mixture of both chemicals 
added together in another sterile Centrifuge Tube Con-
ical Bottom of 50ml capacity and vortex it for 5 min. 
This newly prepared mixture of PLGA and Fadrozole 
was added at a constant flow rate (0.2 ml/min) to 1 lt. 
capacity beaker which contain 500 ml an aqueous 
phase containing 1% (w/v) poloxamer-188 at a under 
mechanical stirring at 10,000 rpm. The organic phase 
was evaporated at room temperature with constant 
stirring for 5 h. Finally the nanoparticles were isolated 
by centrifugation at 17500 rpm 4◦C for 40 min. 
Characterization of nanoparticles: Measurement of 
size with zeta potential was carried out by using Hori-
ba nano Partica SZ-100 series (Japan) which is based 
on dynamic light scattering (DLS) technique. Depend-
ing on the physical properties of the sample, the dy-
namic range of the equipment was 0.3 nm to 8 µm. 
Analysis of the charge on the surface or zeta potential 
of particles is performed by injecting the sample into a 
disposable cell and a measurement of the Electropho-
retic mobility. This calculates zeta potential. The zeta 
potential of the sample is most often used as an indica-
tor of dispersion stability. Large magnitude zeta poten-
tial values indicate that an electrostatically stabilized 
suspension will remain stable.  The surface morpholo-
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(Chemical Formula / Structure Source: Sigma Catalogue 2016-17)  
Chemical Name Chemical Formula / Structure Manufa-cturing Firm Toxicity 
Poly(D,L-lactide-co–
glycolide) lactide:glycolide 
(50:50), mol wt 30,000 - 
60,000, 
 
SIGMA-ALDRICH Nil 
Fadrozole hydrochloride (4
-(5,6,7,8-
Tetrahydroimidazo[1,5-a]
pyridin-5-yl)-benzonitrile) 
≥98% (HPLC) 
 
SIGMA-ALDRICH Nil 
Poloxamer 188 
(Kolliphor® P 188 
 
SIGMA-ALDRICH Nil 
Ethylene glycol 
anhydrous, 99.8% 
  
HOCH2CH2OH 
SIGMA-ALDRICH Nil 
Other Chemicals and Sol-
vents (Analytical grade) 
----- Merck India Nil 
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 gy (roundnesss, smoothness and formation of aggre-
gates) was studied by Atomic Force Microscopy and 
scanning electron microscope.  
Preparation of diet: The treatment diet used in pre-
sent study was  the Firest Bite. Which is commercially 
available hatchling and fry feed procured from Hikari, 
Japan. About 100g of feed was weighed and used for 
incorporation of PLGA conjugated Fedrazole. 
Incorporation of FDZ-loaded PLGA NPs into fish 
feed: PLGA NPs conjugated FDZ were incorporated 
into the feed as follows: The appropriate amount of 
FDZ-loaded PLGA NPs i.e. 5, 25, 50 and 100 mg 
(weighed accurately using an electrical balance) was 
dissolved in 50ml of 95% acetone. The required quantity 
of powdered feed was taken in an enamel tray and the 
FDZ-loaded PLGA NPs dissolved in acetone were 
sprayed uniformly using a chromatogram column sprayer. 
Preparation of negative control: The negative con-
trol diet was prepared in the same manner using only 
the solvent (acetone). 
Preparation of positive control: The positive control 
diet was prepared in the same manner using only 
100mg pure Fadrozole in the solvent (acetone). 
Incorporation of PLGA NPs into fish feed: Incorpo-
ration of PLGA nanoparticles into the fish feed was 
accomplished as follows: The appropriate amount of 
PLGA nanoparticles that is 100 mg (weighed accurate-
ly using an electrical balance) was dissolved in 50ml 
of 95% acetone. The 10 gm of powdered feed was tak-
en in an enamel tray and the PLGA nanoparticles dis-
solved acetone was sprayed uniformly using a chroma-
togram column sprayer. 
Development of brood-stock: The brooders were 
reared in cemented tank (6×4×3ft) until they are ma-
tured. The gravid female and male tilapia were re-
leased in aquaria (2×1×1ft) in the ratio of 2:1 (F: M). 
Table 1. Male, female and survival percentage of different treatments at different time interval. 
Treat-
ment   
  
 10 days  15 days   30 days   
Male 
(%) 
Female
(%)  
Survival 
(%)  
Male(%)  Female
(%)  
Survival 
(%) 
Male(%) Female
(%)  
Survival 
(%) 
 T1  48.48a±1.51  51.51e±1.51  85.92±3.72  47.15a±0.51  52.84e±0.51  94.28±1.64  47.40a±0.78  52.59c±0.78  96.66±5.84 
 T2  65.87c±0.79  34.12d±0.79  85.92±4.54  70.05c±0.77  29.94c±0.77  92.38±2.43  88.96b±1.69  11.03b±1.69  100.00±3.84 
 T3  48.45a±0.90  51.54e±0.90  85.18±4.63  47.25a±0.54  52.74e±0.54  94.28±0.12  47.24a±0.94  52.75c±0.94  96.66±6.14 
 T4  55.08b±0.40  44.91e±0.40  89.62±1.91  58.37b±0.65  41.62d±0.65  93.33±1.52  89.31b±1.97  10.68b±1.97  98.88±4.01 
 T5  78.39d±1.42  21.60c±1.42  87.40±4.14  85.21d±1.23  14.78b±1.23  92.38±1.62  95.92c±2.09  4.08a±2.09  97.77±1.11 
 T6  88.76e±1.07  11.23b±1.07  85.18±3.22  95.53e±0.89  4.46a±0.89  93.33±1.44  100.00a  0.00a  97.77±4.85 
 T7  92.35f±0.86  7.64a±0.86  85.18±5.10  97.76e±1.12  2.23a±1.12  92.38±1.62  100.00a  0.00a  95.55±6.75 
 P value  <0.001  <0.001  0.985  <0.001  <0.001  0.985  <0.001  <0.001  0.985 
Table 2. The particle size, zeta-potential and poly dispersive index a PLGA and FDZ-loaded PLGA NPs. 
 Nanoparticles Particle size (nm)  Zeta potential  Poly dispersive index / 
normal Standard Deviation 
PLGA 136±74.7 -18.20 mv 0.547 
FDZ- PLGA 201.4±66.7 -20.82 mv 0.331 
Fig. 1. Three-Dimension AFM image of FDZ-loaded PLGA. 
NPs. 
Fig. 2. SEM image of FDZ-loaded PLGA NPs. 
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 The fish were fed twice daily on artificial diet as well 
as mosquito larvae, tubifex, bloodworm, earth worm 
and zooplankton at libido. 
Seed production of tilapia: The female and male 
brooders were placed in a big aquarium with muddy 
bottom to released eggs and sperm. After fertilization the 
female takes all eggs into her mouth for the incubation 
upto free swim. The resultant fry were used for experi-
mentation. The aquaria were aerated using an air blower. 
FDZ-loaded PLGA NPs administration to fry 
Trial 1: This trial was conducted for 10 days. The two-
day-old spawn (initial weight 6.13mg) were divided into 
7 groups of 35 each and designated as T1, T2, T3, T4, T5, T6 
and T7 for negative control, positive control, PLGA nano-
particle (100 ppm) and 5, 25, 50 and 100ppm of FDZ-
loaded PLGA NPs respectively. Fishes were fed daily 
(100% body weight) for the first ten days. 
Trial 2: This trial was conducted for 15 days. The one-
day-old spawn (initial weight 3.98mg) were divided into 
7 groups of 30 each and designated as T1, T2, T3, T4, T5, T6 
and T7 for negative control, positive control, PLGA nano-
particle (100 ppm) and 5, 25, 50 and 100ppm of FDZ-
loaded PLGA NPs respectively. They were fed daily @ 
100% body weight for the first ten day and 75% for the 
next 5 days (11th and 15th day). 
Trial 3: This trial was conducted for 30 days. The two-
day-old spawn (initial weight 4.0mg) were divided into 7 
groups of 45 each and designated as T1, T2, T3, T4, T5, T6 
and T7 for negative control, positive control (100ppm pure 
Fadrozole without nanoparticles), PLGA nanoparticle 
(100 ppm) and 5, 25, 50 and 100ppm of FDZ-loaded 
PLGA NPs respectively. They were provided feed daily 
@ 100% body weight for the first ten days, 75% for the 
next 15 days and 50% for the last 5 days. 
Evaluation of all treatments: On termination of the ex-
periments, all the surviving fish were harvested, counted 
and measured for weight and length and sexed by simple 
light macroscopic inspection. The phenotypic sex of the 
treated and control fish was determined with the help of 
secondary sexual characters, such as the shape of the bel-
ly, presence of number of gonopore.  
Statistical analysis: Data on percentage of male pro-
duced in each treatment was analyzed using one way 
ANOVA   to test the significant difference of mean val-
ues and standard error using SPSS 18 software. 
RESULTS AND DISCUSSION  
Physiochemical characterization of nanoparticles:  In 
the present study, the Fadrozole loaded PLGA Nanoparti-
cles (FDZ-PLGA NPs) were prepared by using solvent 
displacement technique as per the reported method with 
some alteration had particle size be in the range of 
60±66.7 nm to 560±66.7 nm with an average size of 
201.4±66.7 nm and zeta potency about -20.82mV (Table 
2, Fig. 1, 2). Three trials were made to test the efficiency 
of FDZ-PLGA NPs to induce the masculinization in re-
search animal. FDZ-loaded PLGA NPs were prepared by 
solvent displacement technique. This yielded spherical 
powder particles with diameter of LTZ-loaded PLGA 
nanoparticles 15–100nm. The loading efficiency as well 
as drug entrapment efficiency of LTZ-loaded PLGA NPs 
was 77.44±0.24and 43.03±2.20%, respectively. The zeta 
potential values of LTZ-loaded PLGA NPs were found to 
be negative, −12 to −19.50 mV (Mondal et al., 2010). 
The dexamethezone in PLGA nanoparticles was devel-
oped for treating disease like rheumatoid, (Park et al., 
2012) the average size was 50 nm with drug loading effi-
ciency was 56.18±5.39 %. 
This is justified that the developed nanoparticle size oc-
curred in between the reported nanoparticles size which is 
cited above and particles are morphologically spherical 
and compact and shown more stable. 
Male and female percentage and survival rate: Gener-
ally, Fadrozole shows effects on sex ratio, increases in 
percentage of male production with directly proportional 
to the dose of FDZ-loaded PLGA NPs. (Tables 1). The 
survival percentage of fry (Tables 1) observed that there 
was no mortality observed in the FDZ-loaded PLGA NPs 
fed experimental fishes. It is indicated that the use of FDZ
-loaded PLGA nanoparticles in Tilapia (Oreochromis 
niloticus) is reasonably safe for masculinization of fish. 
The male percentage was 92.35±0.86 for T7 at 10 days, 
97.76±1.12 for T7 at 15 days and 100 % for both T6 
(50ppm) and T7 (100 ppm) at 30 days, Lowest male 
percentage was found at T4 treatment of all groups. It 
was reported that the male percentage of treatment T2 
(naked fadrozole at 100 ppm) and Treatment T4 (FDZ- 
PLGA NPs at 5 ppm) were 88.96 % and 89.31 % respec-
tively for 30 days treatment (Trial 3). These finding 
shows that FDZ in nano forms can reduce 90% of pre-
scribed dose of fadrozole for masculinization of commer-
cial fish like tilapia.  
It was observed that the percentage of male production in 
treatment T4 during 10 and 30 days‟ time interval was 
increased from 55.08 to 89.31 %. It is „therefore‟ admin-
istrated  FDZ- PLGA NPs at low dose ( 5 ppm per kg) for 
prolong period, presented significant sex reversal and also 
helped  to reduce cost of drug and its adverse impact on 
Oreochromis niloticus. The sex ratio was significantly 
(P<0.001) altered in the FDZ-PLGA NPs treated groups 
in  compare to control groups in all treatments with re-
spect to trials and doses except T3 which has  PLGA na-
noparticle without Fadrozole (drug) and check the impact 
of nanoparticle on experimental fishes (Table 1). Among 
LTZ-loaded PLGA nanoparticles treated groups, the low-
est percentage of males (82.63%) was observed in 5ppm 
group; while the highest percentage of males (100%) was 
found at 50 and 100 ppm when fed for 30 days. Das 
(2007) observed that the manipulation of the sex ratio in 
O. mossambicus was possible by oral administration of 
letrozole (a non-steroidal aromatase inhibitor). Dietary 
administration of letrozole (100 and 200 ppm) was pro-
duced 92-100% males when fed to 5-6 day-old-fry for 30 
days. 
Harshavardhan D. Joshi et al. / J. Appl. & Nat. Sci. 9 (4): 1921 -1925 (2017) 
1924 
 In the recent past decade the Fadrozole a non-steroidal 
aromatase inhibitor has been broadly used to operate the 
sex ratio and its effects on gonadal development in Nile 
tilapia (Kwon et al., 2000 ) (Kwon et al., 2001 ) (Kwon et 
al., 2002), common carp (Pandian, T.J and Varadaraj, K., 
1987), etc. Fadrozole inhibiting the aromatase enzyme by 
quickly joining to the heme of the cytochrome P450 sub-
unit of the enzyme, resulting in a reducing of estrogen 
biosynthesis in all tissues that can result in an elevated 
level of androgen (by preventing the conversion of andro-
gens to estrogens), thus leading sex reversal from genetic 
female to phenotypic male. In India, 100% male popula-
tion in O. mossambicus by administering17α MT through 
rearing medium to 7 or 10 days old fry for a period of 11-
19 days at dosage of 5 and 10 µg/ l water. (Das et al., 
2007) it is possible to manipulate the sex ratio by letro-
zole (a non-steroidal aromatase inhibitor) in the O. mos-
sambicus by oral administration. It is observed that LTZ-
loaded PLGA nanoparticles treated groups, the lowest 
percentage of males (82.63%) was observed in 5ppm 
group; while the highest percentage of males (100%) was 
found at 50 and 100 ppm when fed for 30 days (Joshi et 
al., 2015). The results showed an increase in the propor-
tion of males with dosage and duration of treatment and 
cited reported works supported the present work. 
Conclusion  
The results stated developed a new Fadrozole (FDZ)-
loaded PLGA nanoparticles for effective delivery of the 
masculinization drug. The use of nanoparticles signifi-
cantly showed the effect on masculinization as compared 
with naked drug delivery. This type of Nano encapsulated 
drug can be prepared easily and economically by  using 
standard protocol at farm level lab by using only magnet-
ic stirrer with basic lab equipment. 
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